FROM OUR EXPERTS
This question has not been answered by one of our experts yet.
This summer, health news was dominated by information on the H1N1 flu virus. And just like a child’s game of “telephone,” the facts about the disease got mixed up by the time they’d traveled person to person. So we’ve put together a list of the most important swine flu facts and myths, as well as information on what you can do to keep you and your family healthy this cold and flu season. How many people have been affected? According to the U.S. Centers for Disease Control and Prevention (CDC), there have been 556 deaths from H1N1 as of late August, and 8,843 patients hospitalized because of the disease. More importantly, the CDC has found that the rates of hospitalization of H1N1 patients are similar to the number of people hospitalized for the seasonal flu every year. What about the number of people predicted to get it? Some health organizations believe there may be anywhere from 30,000 to 90,000 deaths from swine flu this year, and though those numbers can ...
Alternative Names Hemorrhagic dengue; Dengue shock syndrome; Philippine hemorrhagic fever; Thai hemorrhagic fever; Singapore hemorrhagic fever Symptoms Early symptoms of dengue hemorrhagic fever are similar to those of dengue fever, but after several days the patient becomes irritable, restless , and sweaty. These symptoms are followed by a shock -like state. Bleeding may appear as tiny spots of blood on the skin ( petechiae ) and larger patches of blood under the skin ( ecchymoses ). Minor injuries may cause bleeding. Shock may cause death. If the patient survives, recovery begins after a one-day crisis period. Early symptoms include: Decreased appetite Fever Headache Joint aches Malaise Muscle aches Vomiting Acute phase symptoms include: Restlessness followed by:
Ecchymosis Generalized rash Petechiae Worsening of earlier symptoms Shock-like state
Cold, clammy extremities Sweatiness (diaphoretic) Signs and tests A physical examination may reveal: Enlarged liver (hepatomegaly) Low blood pressure Rash Red eyes Re...
Healthy older adults with no symptoms of Alzheimer’s disease are the focus of a large study involving 61 medical centers across the U.S., Canada and Australia. The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s study aims to find out if Eli Lilly’s solanezumab, which failed in earlier studies to help people with Alzheimer’s symptoms, will help prevent Alzheimer’s if given long before symptoms appear. Solanezumab did show some promise in the earlier clinical trials for people who had mild cognitive impairment (MCI) which can signal an early stage of Alzheimer’s disease.
The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s study is one of four NIH-supported Alzheimer’s studies to focus on innovative treatments, thus the umbrella name A4.
Lead researcher Reisa Sperling, professor in neurology at Harvard Medical School and director of the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospit...
You should know
Answers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.